JAQBO® Tab. 20 mg(Zastaprazan Citrate) in Erosive GERD
NCT07115706 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 7150
Last updated 2025-08-14
Summary
The purpose of this study is to evaluate the effectiveness and safety of JAQBO® Tab. 20 mg(Zastaprazan citrate) patients who have been prescribed the investigational drug.
Conditions
- Erosive Gastroesophageal Reflux Disease
Sponsors & Collaborators
-
Jeil Pharmaceutical Co., Ltd.
lead INDUSTRY
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-25
- Primary Completion
- 2026-07-31
- Completion
- 2026-07-31
More Related Trials
-
A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD)
NCT00216489 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Study of Ilaprazole to Treat Erosive Esophgitis
NCT01509261 ·Status: COMPLETED ·Phase: PHASE3
-
The Clinical Significance of Minimal Change in Reflux Esophagitis Based on the Gastroesophageal Reflux Disease Questionnaire
NCT00901004 ·Status: COMPLETED
-
Heartburn, Gastroesophageal Reflux Disease
NCT07268820 ·Status: RECRUITING ·Phase: PHASE4
-
Comparing the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD)
NCT00911534 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Study of XP19986 in Subjects With Symptomatic GERD
NCT00557401 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Proton Pump Inhibitors on CF Pulmonary Exacerbations
NCT01983774 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study of Jinsang Liyan Capsules Combined With PPI in the Treatment of LPRD
NCT05879029 ·Status: RECRUITING ·Phase: PHASE4
-
Endoscopic Fundoplication Versus Proton Pump Inhibitors for GERD Treatment
NCT00857597 ·Status: TERMINATED ·Phase: PHASE3
-
Validation of RDQ Questionnaire
NCT00291746 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD)
NCT01161602 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
NCT01022970 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of AGSPT201 Tablet to Treat Gastroesophageal Reflux Disease
NCT01400945 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease
NCT07160790 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive Esophagitis
NCT00471094 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study
NCT00235677 ·Status: COMPLETED ·Phase: PHASE3
-
Electronic Health Record (EHR)-Based Intervention for Gastroesophageal Reflux Disease (GERD) and Chronic Non-steroidal Anti-inflammatory Drug (NSAID) Use
NCT00691171 ·Status: COMPLETED
-
Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD)
NCT00222170 ·Status: COMPLETED ·Phase: PHASE2
-
Retrospective Observational Study on GERD Management in General Hospitals in Korea
NCT06974903 ·Status: COMPLETED
-
Measurement of Gastric Secretion by MRI Under Inhibition by ProtonPump Inhibitors in Healthy Subjects & in GERD Patients
NCT01212614 ·Status: COMPLETED ·Phase: NA
-
Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid Suppression
NCT00234117 ·Status: COMPLETED ·Phase: NA
-
Acid Reflux and Stromal Fibroblasts in Barrett's Esophagus
NCT00573911 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPI
NCT00587275 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of Dexlansoprazole in Healing and Maintaining Healing of Erosive Esophagitis
NCT02873702 ·Status: TERMINATED ·Phase: PHASE3
-
Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients
NCT00394472 ·Status: COMPLETED ·Phase: PHASE2